NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States. Food and Drug Administration. Remove constraint Subjects: United States. Food and Drug Administration.

Search Results

111. Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use : guidance for industry and Food and Drug Administration staff

112. Same surgical procedure exception under 21 CFR 1271.15(b): questions and answers regarding the scope of the exception

113. Unique device identification: direct marking of devices : guidance for Industry and Food and Drug administration staff

114. General principles for evaluating the abuse deterrence of generic solid oral opioid drug products

115. Pediatric information for x-ray imaging device premarket notifications: guidance for industry and Food and Drug Administration staff

116. Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry

117. FDA categorization of investigational device exemption (IDE) devices to assist the Centers for Medicare and Medicaid Services (CMS) with coverage decisions: guidance for sponsors, clinical investigators, industry, institutional review boards, and Food and Drug Administration staff

118. Technical considerations for additive manufactured medical devices: guidance for industry and Food and Drug Administration staff

119. Use of serological tests to reduce the risk of transmission of Trypanosoma cruzi infection in blood and blood components

120. Software as a medical device (SAMD): clinical evaluation : guidance for industry and Food and Drug Administration staff